Proteomic Response of A549 Lung Cancer Cell Line to Protein-polysaccharide Complex Venetin-1 Isolated from Earthworm Coelomic Fluid
Overview
Authors
Affiliations
Earthworms' celomic fluid has long attracted scientists' interest due to their toxic properties. It has been shown that the elimination of coelomic fluid cytotoxicity to normal human cells was crucial for the generation of the non-toxic Venetin-1 protein-polysaccharide complex, which exhibits selective activity against cells as well as A549 non-small cell lung cancer cells. To find the molecular mechanisms behind the anti-cancer properties of the preparation, this research investigated the proteome response of A549 cells to the presence of Venetin-1. The sequential window acquisition of all theoretical mass spectra (SWATH-MS) methodology was used for the analysis, which allows for a relative quantitative analysis to be carried out without radiolabelling. The results showed that the formulation did not induce significant proteome responses in normal BEAS-2B cells. In the case of the tumour line, 31 proteins were up regulated, and 18 proteins down regulated. Proteins with increased expression in neoplastic cells are mainly associated with the mitochondrion, membrane transport and the endoplasmic reticulum. In the case of altered proteins, Venetin-1 interferes with proteins that stabilise the structures, i.e., keratin, glycolysis/gluconeogenesis and metabolic processes.
The Promoting Effect of Animal Bioactive Proteins and Peptide Components on Wound Healing: A Review.
Fan X, Ye J, Zhong W, Shen H, Li H, Liu Z Int J Mol Sci. 2024; 25(23).
PMID: 39684273 PMC: 11640812. DOI: 10.3390/ijms252312561.
Preliminary proteomic analysis of mouse lung tissue treated with cyclophosphamide and Venetin-1.
Czaplewska P, Muller M, Musial N, Okroj M, Felberg-Mietka A, Sadowska J Sci Rep. 2024; 14(1):25056.
PMID: 39443613 PMC: 11499674. DOI: 10.1038/s41598-024-76143-0.
Prospects of earthworm coelomic fluid as a potential therapeutic agent to treat cancer.
Haque S, Hussain A, Almalki A, Aldawsari M, Lal B, Rai A Cancer Metastasis Rev. 2023; 43(2):621-637.
PMID: 37910294 DOI: 10.1007/s10555-023-10148-5.